FCNCA:NASDAQFirst Citizens BancShares, Inc. Analysis
Data as of 2026-03-11 - not real-time
$1,912.46
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
First Citizens BancShares (FCNCA) is trading at $1912.46, just below its 20‑day SMA of $1,988.6 but above the 200‑day SMA of $1,950.5, indicating a modestly bullish medium‑term bias. The RSI of 39 points to a near‑oversold condition, while the MACD remains bearish, suggesting short‑term downside pressure yet ample room above the $1,819.7 support level. Valuation metrics are attractive: a trailing P/E of 11.6 versus the industry average of 17.3 and a P/B of 1.11 signal a potential discount, though the DCF‑derived fair value of $1,670.3 implies the market price is modestly premium. The stock’s dividend yield is low at 0.44% with a payout ratio of just 4.8%, underscoring strong dividend sustainability given its $21.4 B cash pile.
Recent material news adds a positive catalyst mix: analysts expect an earnings beat, the CEO’s appointment to the Federal Advisory Council enhances regulatory credibility, and the firm is actively scouting M&A opportunities, including a rumored pursuit of KeyCorp. However, an investor‑focused lawsuit investigation introduces a headwind. Overall, the combination of undervalued multiples, solid cash generation, and strategic upside potential supports a cautiously optimistic outlook.
Recent material news adds a positive catalyst mix: analysts expect an earnings beat, the CEO’s appointment to the Federal Advisory Council enhances regulatory credibility, and the firm is actively scouting M&A opportunities, including a rumored pursuit of KeyCorp. However, an investor‑focused lawsuit investigation introduces a headwind. Overall, the combination of undervalued multiples, solid cash generation, and strategic upside potential supports a cautiously optimistic outlook.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Near‑oversold RSI and price cushion above support
- Anticipated earnings beat
- Low payout ratio preserving cash
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Attractive valuation relative to industry peers
- Strong operating margins and ROE
- Potential M&A transactions expanding earnings base
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustainable dividend policy with ample cash reserves
- CEO’s Federal Advisory Council role reducing regulatory uncertainty
- Stable regional banking franchise with diversified product lines
Key Metrics & Analysis
Financial Health
Revenue Growth6.20%
Profit Margin24.41%
P/E Ratio11.6
ROE9.92%
ROA0.97%
P/B Ratio1.1
Op. Cash Flow$2.9B
Industry P/E17.3
Technical Analysis
TrendNeutral
RSI39.3
Support$1,819.68
Resistance$2,197.03
MA 20$1,988.63
MA 50$2,072.15
MA 200$1,950.48
MACDBearish
VolumeStable
Fear & Greed Index76.91
Valuation
Fair Value$1,670.27
Target Price$2,295.07
Upside/Downside20.01%
GradeFair
TypeValue
Dividend Yield0.44%
Risk Assessment
Beta1.14
Volatility33.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.